Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations

Epidermal growth factor receptor (EGFR) is one of the most commonly altered genes in human cancer by way of over-expression, amplification, and mutation. Targeted inhibition of EGFR activity suppresses signal transduction pathways which control tumor cell growth, proliferation, and resistance to apo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wykosky, Jill, Fenton, Tim, Furnari, Frank, Cavenee, Webster K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359794/
https://www.ncbi.nlm.nih.gov/pubmed/21192840
http://dx.doi.org/10.5732/cjc.010.10542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359794/
https://www.ncbi.nlm.nih.gov/pubmed/21192840
http://dx.doi.org/10.5732/cjc.010.10542

Ejemplares similares